
Medications
Ozempic, Wegovy, compounded semaglutide
Monthly Cost
$99-$399
Speed to Start
Fast
Est. 2021
About FuturHealth
FuturHealth has emerged as one of the dominant forces in the GLP-1 telehealth industry, and the data behind that position is staggering. Founded in 2021, the platform has served over 1.5 million patients and accumulated more than 15,750 reviews on Trustpilot with a 4.7-star rating. These are not just impressive numbers β they represent the largest verified review corpus of any GLP-1 telehealth provider we have evaluated, and the near-perfect rating at that scale is remarkable.
The clinical model at FuturHealth goes well beyond basic prescribing. The platform includes lab testing covering 8 biomarkers as part of its standard program, providing meaningful insight into each patient’s metabolic health before and during treatment. FuturHealth also offers access to registered dietitians along with structured meal plans, creating the kind of integrated approach that maximizes the effectiveness of GLP-1 medications. This combination of medication management, laboratory monitoring, and nutritional support puts FuturHealth in elite company among telehealth providers.
Perhaps the most distinctive feature of FuturHealth’s offering is its 10% weight loss guarantee with a money-back promise. This is an extraordinary commitment that we have not seen from any other provider in our review database. It signals deep confidence in the platform’s clinical model and medication efficacy, and it materially reduces the financial risk for patients who are investing in GLP-1 therapy for the first time. The guarantee transforms the value proposition from “try and hope” to “results or your money back” β a powerful differentiator in a crowded market.
FuturHealth offers both brand-name Ozempic and Wegovy as well as compounded semaglutide, with pricing from $99-$399Β per month. This range accommodates patients at different budget levels while maintaining access to the clinical support infrastructure. The Trustpilot profile consistently shows patients praising the quality of medical consultations, the responsiveness of support staff, and the effectiveness of the program overall. Maintaining a 4.7-star average across more than 15,000 reviews requires consistently excellent execution at massive scale.
The platform does not currently have a Better Business Bureau listing, and it does not accept insurance β two areas where there is room for growth. However, these are relatively minor gaps in the context of FuturHealth’s overall offering. With its enormous patient base, industry-leading review profile, comprehensive clinical model including 8-biomarker lab testing and dietitian support, and a unique money-back weight loss guarantee, FuturHealth delivers one of the most compelling and well-validated GLP-1 telehealth experiences available. It narrowly misses our top score only because of the insurance and BBB gaps.
At a Glance
Medications Offered
Ozempic, Wegovy, compounded semaglutide
Both
Cost & Insurance
- Monthly: $99-$399
- 6-month estimate: $594-$2,394
- Insurance: No / not required
- Self-pay: Yes
Clinical Features
- Lab testing: Yes (8 biomarkers)
- Dietitian access: Yes
- Verified Pharmacy: Alto Pharmacy (Fuze Health partner); LegitScript certified; transitioning to FDA-approved brand-name (Wegovy)
- BBB Rating: –
Delivery & Access
- Format: Both (injection + pill options)
- Nationwide telehealth: Yes
- Speed: Fast
- Spanish-speaking providers: Not available
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the FuturHealth Intake Looks Like
We walked through the full FuturHealth funnel at funnel.fh.co. It’s a 45-screen questionnaire that runs through three domains (funnel.fh.co β plus.fh.co β checkout.fh.co), and it is β by a meaningful margin β one of the most clinically thorough shopping-funnel intakes in our catalog. It asks validated PHQ-2 depression items, a dedicated family-history MEN-2 and medullary thyroid cancer screen, pregnancy and breastfeeding status, suicidal thoughts, medication allergies, blood pressure stages, and resting heart rate ranges before it ever asks for the patient’s name. The trade-off is the length and an aggressive urgency-timer checkout.
Top-tier for a public shopping funnel. FuturHealth asks validated PHQ-2 depression items, a dedicated family-history MEN-2 and medullary thyroid cancer screen, pregnancy and breastfeeding, suicidal thoughts, eating-disorder disqualifiers, medication allergies, blood pressure stages, resting heart rate, family heart-disease history, three separate comorbidity screens, bariatric surgery history, and a federal-payer ineligibility check. Does not ask a substance-use or alcohol screen, and does not collect diet or exercise history, ID, or a phone OTP.
High. 45 screens to a checkout and roughly six minutes of uninterrupted work is well above the catalog median. The checkout uses countdown timers (“Your approval expires in 14:44,” “Exclusive price expires in 14:58”), a stacked “$100 off” discount framing, and a pre-selected $198 Wegovy Pill bundle. Partial offset: email and name capture don’t happen until after the clinical questionnaire is complete, so patients who abandon during the clinical section don’t leave a marketing profile behind.
The 6 Stages
Two consecutive screens in the clinical stage ask the first two items of the PHQ-9 (the PHQ-2) using the standard wording: “Over the past 2 weeks, how often have you had little interest or pleasure in doing things?” and “Over the past 2 weeks, how often have you felt down, depressed, or hopeless?” Both use the validated four-point Likert (“Not at all,” “Several days,” “More than half the days,” “Nearly every day”). The earlier disqualifying-conditions screen also includes “Suicidal thoughts” as a checkbox. Mental-health screening of this specificity is uncommon in public GLP-1 shopping funnels β most either skip mental health entirely or fold it into a vague “do you have any mental health conditions” free-text field.
FuturHealth surfaces the FDA black-box contraindication as its own full screen β not buried inside a disqualifying-conditions checklist β with the exact question “Do you or your family have a history of either MEN2 or Medullary Thyroid cancer?” That is a meaningful UX decision. A dedicated screen is harder for a patient to race past than an item deep inside a long multi-select, and it puts the black-box warning front-and-center in a way that matches how the actual prescribing information treats it.
FuturHealth does not hard-gate the clinical questionnaire behind an email or account. The funnel runs through all 37 clinical and lifestyle questions before the “Your Medical Review” card on plus.fh.co asks for a first name and email address at screen 39. A patient who answers the safety screens honestly and discovers they are ineligible β because of pregnancy, MEN-2 family history, end-stage kidney disease, or a disqualifying condition β can back out without leaving a marketing-usable profile behind. That is the opposite of the shopping-funnel norm in this catalog and a meaningful privacy improvement.
Three separate screens in the approval-and-checkout stage display live countdown timers. The first says “Your approval expires in 14:44.” The second says “Exclusive price expires in 14:58.” The third says “Ju, this price is reserved for you right now β Exclusive price expires in 14:21.” These are manufactured-scarcity patterns, not actual prescribing deadlines, and the pricing ($149 for the Wegovy Pill + $49 FH Membership, discounted from $149, totalling $198) is framed through a “$100 OFF DISCOUNT β ACTIVE” banner and a “Lowest Price Ever!” badge. Anyone at this stage of the flow should be aware that the time pressure is a sales tactic and that walking away and coming back later will not cause the approval to disappear.
The medication preference screen lists four name-brand options β Wegovy, Wegovy Pill, Zepbound, and Ozempic β with a footnote beneath the list stating that “The FuturHealth program includes access to both branded medications and customized, compounded medications based on what your clinician determines is medically appropriate and necessary for you. Compounded drug products are not FDA-approved and the FDA does not evaluate compounded products for safety, effectiveness, or quality.” The default checkout bundle that ultimately appears is the branded Wegovy Pill at $149, not a compounded alternative. Patients who specifically want compounded semaglutide or tirzepatide to save money will need to discuss that with the clinician during the follow-up, because the funnel itself does not surface a compounded price path.
There is no substance-use or alcohol-use screen. There is no structured diet history and no exercise history β only the “difficulties” multi-select at the very start. There is no government-ID upload, no phone-number OTP verification, no labs upload, and no weight documentation. The clinical stack is otherwise notably complete, but these four omissions are worth knowing about for patients who are weighing FuturHealth against a more traditional telemedicine model that does bill-and-verify on labs and ID.
Source: GLP-1.Reviews editorial walkthrough on April 15, 2026. We completed every screen of the public FuturHealth weight-loss intake funnel across funnel.fh.co, plus.fh.co, and checkout.fh.co, and stopped before authorizing payment for the pre-selected $198 Wegovy Pill bundle.
Opens futurhealth.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.










